Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20236364rdf:typepubmed:Citationlld:pubmed
pubmed-article:20236364lifeskim:mentionsumls-concept:C0337810lld:lifeskim
pubmed-article:20236364lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:20236364lifeskim:mentionsumls-concept:C0017431lld:lifeskim
pubmed-article:20236364lifeskim:mentionsumls-concept:C1456409lld:lifeskim
pubmed-article:20236364lifeskim:mentionsumls-concept:C0033105lld:lifeskim
pubmed-article:20236364lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:20236364lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:20236364lifeskim:mentionsumls-concept:C0242356lld:lifeskim
pubmed-article:20236364lifeskim:mentionsumls-concept:C1011526lld:lifeskim
pubmed-article:20236364pubmed:issue8lld:pubmed
pubmed-article:20236364pubmed:dateCreated2010-8-10lld:pubmed
pubmed-article:20236364pubmed:abstractTextTo evaluate whether etravirine (TMC125) might be effective in patients failing therapy with current nonnucleoside reverse transcriptase inhibitors (NNRTIs), we analysed the prevalence of TMC125 mutations and the possible determinants of genotypic resistance to this drug among sequences reported to a large database in Italy [Antiretroviral Resistance Cohort Analysis (ARCA)].lld:pubmed
pubmed-article:20236364pubmed:languageenglld:pubmed
pubmed-article:20236364pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20236364pubmed:citationSubsetIMlld:pubmed
pubmed-article:20236364pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20236364pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20236364pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20236364pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20236364pubmed:statusMEDLINElld:pubmed
pubmed-article:20236364pubmed:monthSeplld:pubmed
pubmed-article:20236364pubmed:issn1468-1293lld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:VitielloPPlld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:ZazziMMlld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:AntinoriAAlld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:FrancisciDDlld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:MonnoLLlld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:MaggioloFFlld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:BoeriEElld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:PunzoAAlld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:RusconiSSlld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:Di BiagioAAlld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:CallegariGGlld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:PetitA GAGlld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:BruzzoneBBlld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:AdorniFFlld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:Di VincenzoPPlld:pubmed
pubmed-article:20236364pubmed:authorpubmed-author:Antiretrovira...lld:pubmed
pubmed-article:20236364pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20236364pubmed:volume11lld:pubmed
pubmed-article:20236364pubmed:ownerNLMlld:pubmed
pubmed-article:20236364pubmed:authorsCompleteYlld:pubmed
pubmed-article:20236364pubmed:pagination530-4lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:meshHeadingpubmed-meshheading:20236364...lld:pubmed
pubmed-article:20236364pubmed:year2010lld:pubmed
pubmed-article:20236364pubmed:articleTitlePrevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA).lld:pubmed
pubmed-article:20236364pubmed:affiliationSezione Malattie Infettive e Immunopatologia, Dipartimento di Scienze Cliniche 'Luigi Sacco', Universita' degli Studi, Milan, Italy.lld:pubmed
pubmed-article:20236364pubmed:publicationTypeJournal Articlelld:pubmed